Cellceutix's Clinical Trial of Anti-Cancer Agent Kevetrin Meeting Its Goals, Approaching End of Trial
Good Day Sacramento,
) - Cellceutix Corporation ( OTC: CTIX ) (the "Company"), a clinical stage biopharmaceutical company developing innovative…
) - Cellceutix Corporation ( OTC: CTIX ) (the "Company"), a clinical stage biopharmaceutical company developing innovative…
) - Cellceutix Corporation ( OTC: CTIX ) (the "Company"), a clinical stage biopharmaceutical company developing innovative…
BEVERLY, MA--(Marketwired - August 20, 2015) - Cellceutix Corporation ( OTC: CTIX ) (the "Company"), a clinical stage…
BEVERLY MAMarketwired August 20 2015 Cellceutix Corporation OTC CTIX the "Company" a clinical stage biopharmaceutical company…